Shengtai Pharmaceutical, Inc. Receivables Turnover Ratio (SGTI), from the third quarter 2013 to the third quarter 2012 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Shengtai Pharmaceutical, Inc.  (SGTI)
 

Shengtai Pharmaceutical Accounts Receivables Turnover Ratio from the third quarter 2013 to the third quarter 2012

Quarterly Results, Trends, Rankings, Statistics


Shengtai Pharmaceutical, Inc.'s ability to collect accounts receivable sequentially worsen to 12.63, pointing to a challenging and on top of that deteriorating business climate for the Biotechnology & Pharmaceuticals industry. Shengtai Pharmaceutical's Accounts Receivable average collection period in the Mar 31 2013 quarter, has increased to 29 days, from 28 days, in the Dec 31 2012 quarter.

If we take a look into Healthcare sector 39 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2013 from 0 to 733.

What is Receivable Turnover Ratio?
What is Shengtai Pharmaceutical, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SGTI Receivables Turnover Ratio (Mar 31 2013)
III. Quarter		 (Dec 31 2012)
II. Quarter		 (Sep 30 2012)
I. Quarter		 (Jun 30 2012)
IV. Quarter		 (Mar 31 2012)
III. Quarter
Y / Y Receivable Change 52 % -1.01 % -26.34 % 23.74 % -
Y / Y Revenue Change 24.92 % 49.31 % 21.69 % 28.88 % -4.52 %
Receivable Turnover Ratio (TTM) 12.63 13.12 11.76 10.31 10.17
SGTI's Total Ranking # 733 # 0 # 0 # 0 #
Accounts Receivable average collection period days 29 28 31 35 36
Seq. Receivable Change 3.4 % 1.27 % -24.6 % 92.52 % -32.66 %
Seq. Revenue Change -22.43 % 31.51 % -13.32 % 41.29 % -7.29 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 3
Healthcare Sector # 40
Overall Market # 733

Receivable Turnover Ratio Statistics
High Average Low
19.41 18.92 18.66
(Dec 31 2012)   (Mar 31 2013)





SGTI Company Profile • Back to SGTI Efficiency Comparisons • Compare SGTI Receivables Turnover Ratio to its Competitors

Financial Statements
Shengtai Pharmaceutical's Accounts Receivable $ 17 Millions Visit SGTI's Balance sheet
Shengtai Pharmaceutical's Sales TTM $ 219 Millions Visit SGTI's Income Statement
Sources of SGTI's Revenues Visit SGTI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SGTI's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SGTI's Growth Rates SGTI's Roa SGTI's Inventory Turnover Ratio SGTI's Dividend Comparisons
SGTI's Profitability Ratios SGTI's Roi SGTI's Asset Turnover Ratio SGTI's Dividend Growth
SGTI's Valuation Ratios SGTI's Roe SGTI's Financial Strength Ratios SGTI's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2013, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2013 Receivable at quarter ending Mar 31 2013
Ernexa Therapeutics Inc   33.16 $ 24.114  Millions$ 0.727  Millions
Guided Therapeutics Inc   29.18 $ 2.787  Millions$ 0.096  Millions
Brookdale Senior Living Inc   26.53 $ 2,799.306  Millions$ 105.525  Millions
Cba Florida Inc   26.15 $ 5.889  Millions$ 0.225  Millions
Cytosorbents Corporation  25.94 $ 1.697  Millions$ 0.065  Millions
Assertio Holdings inc   25.52 $ 100.156  Millions$ 3.925  Millions
Northwest Biotherapeutics Inc  25.42 $ 1.239  Millions$ 0.049  Millions
Magellan Health inc   24.75 $ 3,255.945  Millions$ 131.570  Millions
Statera Biopharma Inc fka Cytocom Inc   23.10 $ 4.007  Millions$ 0.173  Millions
Integrated Biopharma Inc  22.91 $ 52.151  Millions$ 2.277  Millions
Grapefruit Usa Inc   22.80 $ 0.966  Millions$ 0.042  Millions
Dexcom Inc   22.45 $ 109.439  Millions$ 4.875  Millions
Alaunos Therapeutics Inc   22.38 $ 0.800  Millions$ 0.036  Millions
Vanda Pharmaceuticals Inc   22.27 $ 32.654  Millions$ 1.466  Millions
U s Stem Cell Inc   22.23 $ 0.025  Millions$ 0.001  Millions
Sunlink Health Systems Inc   20.19 $ 109.496  Millions$ 5.423  Millions
Cyteir Therapeutics Inc   19.04 $ 1,807.500  Millions$ 94.950  Millions
Oragenics Inc   19.03 $ 1.128  Millions$ 0.059  Millions
Clearpoint Neuro Inc   18.72 $ 5.342  Millions$ 0.285  Millions
Shengtai Pharmaceutical, Inc.  18.66 $ 218.808  Millions$ 11.727  Millions
Skinvisible Inc   18.04 $ 0.268  Millions$ 0.015  Millions
Immunogen inc   17.97 $ 34.656  Millions$ 1.928  Millions
Cocrystal Pharma Inc   17.81 $ 15.710  Millions$ 0.882  Millions
Earth Science Tech Inc   17.66 $ 0.068  Millions$ 0.004  Millions
Wearable Health Solutions, Inc.  17.23 $ 0.834  Millions$ 0.048  Millions
Musclepharm Corporation  16.77 $ 73.056  Millions$ 4.357  Millions
Lftd Partners Inc   16.10 $ 3.265  Millions$ 0.203  Millions
Protalix Biotherapeutics inc   15.95 $ 34.577  Millions$ 2.167  Millions
Adma Biologics Inc   15.45 $ 2.501  Millions$ 0.162  Millions
Aspira Women s Health inc   15.18 $ 2.110  Millions$ 0.139  Millions

Date modified: 2026-09-08T15:21:55+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.